Financial Summary (All financials)
In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
Revenues | 25.0 | 263,966.0 | 238,228.0 | 231,051.0 | 214,319.0 | 208,357.0 | 198,533.0 | 190,884.0 |
Revenue growth | -100.0% | 10.8% | 3.1% | 7.8% | 2.9% | 4.9% | 4.0% | 6.6% |
Cost of goods sold | 12,333.0 | 250,836.0 | 226,080.0 | 219,028.0 | 202,565.0 | 197,173.0 | 187,262.0 | 179,468.0 |
Gross profit | -12,307.9 | 13,130.0 | 12,148.0 | 12,023.0 | 11,754.0 | 11,184.0 | 11,271.0 | 11,416.0 |
Gross margin | -49172.8% | 5.0% | 5.1% | 5.2% | 5.5% | 5.4% | 5.7% | 6.0% |
Selling, general and administrative | 7,776.0 | 10,537.0 | 8,849.0 | 9,182.0 | 8,437.0 | 8,138.0 | 7,447.0 | 7,379.0 |
Research and development | | | | | | 125.0 | 341.0 | 392.0 |
EBITA | 4,950.0 | 2,925.0 | 3,721.0 | 3,303.0 | 4,399.0 | 4,174.0 | 7,874.0 | 4,179.0 |
EBITA margin | 19776.3% | 1.1% | 1.6% | 1.4% | 2.1% | 2.0% | 4.0% | 2.2% |
Amortization of intangibles | 360.0 | 332.0 | 422.0 | 462.0 | 485.0 | 503.0 | 444.0 | 431.0 |
EBIT | 4,590.0 | 2,593.0 | 3,299.0 | 2,841.0 | 3,914.0 | 3,671.0 | 7,430.0 | 3,748.0 |
EBIT margin | 18338.0% | 1.0% | 1.4% | 1.2% | 1.8% | 1.8% | 3.7% | 2.0% |
Pre-tax income | 4,630.0 | 1,928.0 | -5,034.0 | 1,144.0 | 610.0 | 239.0 | 6,891.0 | 3,250.0 |
Income taxes | 905.0 | 636.0 | -695.0 | 18.0 | 356.0 | -53.0 | 1,614.0 | 908.0 |
Tax rate | 19.5% | 33.0% | 13.8% | 1.6% | 58.4% | | 23.4% | 27.9% |
Earnings from continuing ops | 3,563.0 | 2,411.0 | -4,538.0 | 2,032.0 | 33.0 | 62.0 | 10,471.0 | 4,632.0 |
Earnings from discontinued ops | -3.0 | -5.0 | -1.0 | -6.0 | 1.0 | 5.0 | -124.0 | -32.0 |
Net income | 3,560.0 | 2,406.0 | -4,539.0 | 2,026.0 | 34.0 | 67.0 | 10,347.0 | 4,600.0 |
Net margin | 14222.9% | 0.9% | -1.9% | 0.9% | 0.0% | 0.0% | 5.2% | 2.4% |
|
Diluted EPS | $25.06 | $15.65 | ($28.26) | $11.19 | $0.17 | $0.30 | $46.96 | $19.88 |
Shares outstanding (diluted) | 142.2 | 154.1 | 160.6 | 181.6 | 197.3 | 209.0 | 223.0 | 233.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|